Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04217512
PHASE3
Pantoprazole in Cisplatin Nephrotoxicity
Sponsor: Sherief Abd-Elsalam
View on ClinicalTrials.gov
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Official title: Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2019-05-01
Completion Date
2030-12-30
Last Updated
2020-01-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
Pantoprazole low dose
Pantoprazole 0.6 mg/kg
DRUG
Pantoprazole high dose
Pantoprazole 1.6 mg\\kg
OTHER
Standard hydration
Standard hydration alone
DRUG
Cisplatin
Cisplatin
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt